1ZL.F Zai Lab Limited

Healthcare Biotechnology Frankfurt Exchange
23.40 EUR
Close of Nov 12, 2026
13.20 23.60
Market cap
EUR 2.90B
P/E
-
P/B
5.72x
ROE
-35.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 1ZL.F undervalued?

Graham number

The Graham number of Zai Lab Limited cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zai Lab Limited fundamental analysis

No fundamental analysis for Zai Lab Limited yet.

Zai Lab Limited stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zai Lab Limited

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropa…

Full company profile